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INTRODUCTION:  Autoimmune  pancreatitis  (AIP)  is a rare pancreatic  disorder  among  chronic  pancreatitis
that  can  mimick  pancreatic  cancer  (PC).  Patients  with  type  1 AIP  usually  present  obstructive  jaundice
associated  with  high  level  of IgG4  in  serum  and  a pancreatic  mass  at radiological  imaging;  these  disorders
may  be  associated  with  other  organs  lesions  presenting  the  same  histopathological  features,  and  in these
cases  AIP  should  be  considered  a pancreatic  localization  of  an  IgG4-related  systemic  disease.
PRESENTATION  OF CASE:  We  report  the  case  of a young  man  with  initial  suspect  of PC  to  be treated  with
surgery,  and ﬁnal  diagnosis  of  AIP  in  the  context  of  an  IgG4-related  systemic  disease.ancreatic cancer DISCUSSION:  Because  of  its similar  features,  several  algorithms  have  been  proposed  for  AIP  diagnosis,
based  on combination  of clinical/serological  and radiological  criteria.  However,  histology  represents  the
only way  to obtain  deﬁnitive  diagnosis,  even  if  sometimes  it is difﬁcult  to obtain  biological  samples.
CONCLUSION:  IgG4-related  systemic  disease  must  be taken  into  account  among  differential  diagnosis
during  the workup  for PC,  in order  to avoid  unnecessary  surgery.
© 2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
 the Caccess  article  under
. Introduction
Autoimmune pancreatitis (AIP) is a rare pancreatic disorder that
n recent years is drawing the attention of many clinicians because
f the differential diagnosis with pancreatic cancer (PC). It com-
rehends two different varieties: type 1 or lymphoplasmocytic
clerosing pancreatitis, and type 2 or idiopatic duct-centric pan-
reatitis. The ﬁrst is characterized by inﬁltration of a high number
f IgG4 positive plasma cells (IgG4-related), while the second by
eutrophilic inﬁltration in pancreatic duct epithelium (IgG4 not-
elated).1 Type 1 is more frequent than type 2 and it occurs usually
n adult men. Pathogenesis is not completely known but immuno-
ogical mechanisms seem to be implicated. Patients with AIP may
resent obstructive jaundice associated with high level of IgG4 in
erum and a pancreatic mass at radiological imaging. They can
lso show other organs involvement (IgG4-related sistemic dis-
ase), and typically the response to steroid treatment is good.1
IP shares some clinical and radiological features with PC: many
ases of diffuse type of AIP can be correctly diagnosed on the basis
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of the various diagnostic algorithms proposed, but mass-forming
AIP is very similar to PC ad it may  be really difﬁcult to distinguish
between the two entities. We  report the case of a young man  with
initial suspect of PC to be treated with surgery, and ﬁnal diagnosis
of AIP in the context of an IgG4-related sistemic disease.
2. Case report
A 46-years old man  was admitted in a peripheral hospital for
jaundice associated with progressive asthenia and weight loss. Lab-
oratory tests showed elevated bilirubin (6, 9 mg/dl) ad hepatic
enzymes (AST/ALT 107/176 UI/L, GGT 760 UI/L). CA 19-9 was
negative. CT scan showed a mass in pancreatic head (diame-
ter 42 mm × 28 mm)  (Fig. 1A), with mild Wirsung and bile ducts
dilatation and suspected encasement of superior mesenteric vein
(Fig. 1B); both kidneys presented increased size. At that time patient
was transferred to our institution for surgical treatment. A pan-
creatic EUS-FNA was  performed: EUS evidenced a pancreatic head
mass (diameter 45 mm),  with doubt of encasement of the mesen-
teric vein; Wirsung and common bile duct were enlarged; multiple
pericaval and peripancreatic limphnodes were present. Patholo-
gists did not found carcinoma cells but they were not able to
perform a deﬁnitive diagnosis. Histopatological assessment was
ssociates Ltd. This is an open access article under the CC BY-NC-SA license
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erformed, but IgG positive plasmacells were few, and it was
ot possible to evaluate the IgG4 percentage. A second CT scan
howed diffuse head pancreatic enlargement and atropy of the
ale with a Wirsung segmental dilatation. Both kidneys presented
bnormal parenchyma with pseudonodular images (Fig. 2). Other
nvestigations were performed: serum Ig level, C3–C4 and auto-
ntibodies resulted normal, but serum IgG4 level was 180 mg/dl
ref. 30–90 mg/dl). Patient underwent kidney biopsy, that showed
nterstitial nephritis IgG4-related. After starting with steroid treat-
ent, patient clinical conditions and laboratory tests improved.
ne month later, CT scan showed normalization of the kidneys with
eduction of the pancreatic lesion (Fig. 3) and of the peripancre-
tic limphnodes. Bilirubin and hepatic enzymes were normal. Six
onth later, CT scan did not evidence pancreatic lesions.
. Discussion
The case proposed demonstrated how clinical and radiolog-
cal presentation of AIP can be similar to that of PC. Thus, AIP
hould be considered among differential diagnosis of PC in order
o avoid unnecessary pancreatic resections; some studies reported
hat 2–5% of pancreatic lesions resected with suspect of PC turned
ut to be AIP at histological analysis.2,3 Consequently, it should be
ery important to do a correct diagnosis of AIP before surgery. In
011 the International Association of Pancreatology proposed the
nternational Consensus Diagnostic Criteria (ICDC) for AIP.4 Pre-
enting all cardinal features of AIP, ICDC evidenced elements to
ifferentiate AIP from PC. First, clinical presentation of AIP can be
cute, with obstructive jaundice by a pancreatic mass, or chronic
ig. 2. Second CT scan: both kidneys present abnormal parenchyma with pseudon-
dular images and incremented volume.2 mm × 28 mm.  Portal phase (B): suspected involvement of the superior mesenteric
with symptoms of chronic pancreatitis (pain, diarrhea, diabetes).4
In AIP jaundice can sometimes ﬂoat (as in our patient) or even
spontaneously attenuate, while in PC jaundice progresses steadily5.
In 50–70% of cases AIP is associated with other organs lesions
(retroperitoneal ﬁbrosis, interstitial nephritis, sclerosing cholan-
gitis) with the same histopathological features; these disorders
are known as IgG4-related disease. Extrapancreatic alterations can
occur also in absence of pancreas involvement.6,7 Our patient
showed the association of AIP and interstitial nephritis as mani-
festation of IgG4-related sistemic disease. As regards serology, a
marked elevation of serum IgG4 (>2 times upper normal limit)
is suggestive of type 1 AIP, but false positive elevation can occur
also in PC.4 Radiological ﬁndings are different in AIP and PC;
abdominal CT/RMN generally show in AIP a diffuse enlargement
of the pancreas associated with a typical capsule-like rim and
delayed contrast enhancement; on the other hand patients with
PC commonly present a mass that takes poor contrast enhance-
ment in pancreatic phase and distal pancreas atrophy.4,8 Our
patient presented atypical radiological pattern of AIP, such as a
low-density mass of the pancreatic head, a distal pancreas atro-
phy and a Wirsung dilatation; in these cases differential diagnosis
between the two disorders is more difﬁcult. A peculiar feature of
AIP is the response to steroid treatment; however, corticosteroid
diagnostic therapy is not generally recommended, and it should
only be performed in carefully selected patients after obtaining
negative results from a work-up for pancreatic cancer, including
EUS-FNA. Finally, histology can give deﬁnitive diagnosis of AIP since
histopathological pattern is diagnostic for type 1 AIP; typical fea-
tures are: elevated plasma cells and lymphocytes inﬁltration, high
Fig. 3. CT scan one month after starting steroid therapy: kidneys morphological
normalization and reduction of the pancreatic lesion (33 mm × 23 mm).
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umber (>10 cells per HPF) of IgG4 positive plasma cells, storiform
brosis, venulitis.4 Reported accuracy and sensitivity of EUS-FNA
or diagnosis of pancreatic neoplasm ranges from 75 to 79% to
2%.9 According to Eloubeidi in case of difﬁcult differential diagno-
is between AIP and PC, EUS-FNA should be recommended during
he diagnostic workup.10 However, deﬁnitive diagnosis of AIP by
US-FNA may  be difﬁcult, because of the small sample obtained;
n our experience EUS-FNA was not diagnostic, and we performed
he right diagnosis only after the renal biopsy.
. Conclusion
AIP can mimic  PC, and it could be the pancreatic localization
f an IgG4-related sistemic disease. For patients presenting with
bstructive jaundice and a pancreatic mass, AIP should be con-
idered as a differential diagnosis to avoid unnecessary surgery.
robable diagnosis of AIP may  be currently obtained based on
areful consideration of a combination of clinical/serological and
adiological criteria, eventually extended to other organs involved.
eﬁnitive diagnosis of mass-forming AIP is possible only with
istological examination; the role of histology is crucial, even if
ometimes it is difﬁcult to obtain adequate biopsy material.
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